Sidibé was received by the mayor of Santiago, Carolina Toha, who committed the capital of Chile to achieve the proposed actions suggested in the Paris Declaration by UNAIDS, which calls for an end to the AIDS epidemic by the year 2030.
“It is essential to highlight that all municipalities have the task of working together to achieve these very ambitious goals. We are implementers of health policies, as well as all municipalities in Chile. We must build a bridge between those policies and the populations that are vulnerable”, said Mrs. Toha.
Several organizations working in the HIV response in the country, took the opportunity to dialogue with the representative of UNAIDS and unveiled a joint statement signed by 25 organizations, which reflects a national reality that the community response is currently facing.
The Declaration also acknowledges the weakening of citizen participation spaces, both groups of people with HIV, as well as organizations that work with the most vulnerable populations.
A central topic during the visit of Michel Sidibé was related to funding that countries of average income are facing in the HIV response, as it is the case of Chile. The National Coordinator on HIV and AIDS read a written statement which explained that although the macroeconomic indicators of Chilean economy are important for the prestige of the country before the international community, they are a serious obstacle for the response to HIV, since the State does not grant regular financing to civil society oriented to stop the epidemic, and international cooperation does not support actions.
Finally, the Executive Director of UNAIDS in a meeting with President Michelle Bachelet, who committed their support to the response to HIV and promised that Chile would be the second country in the world to eliminate mother-to-child transmission, also announced that the interest and the alert of local social movements has weaken up, who have pointed out that despite this progress, Chile presents serious challenges in preventing infection in women of childbearing age, improvement in clinical trials as the testing, monitoring and audit cases and opportunity of having the appropriate information for the adoption of corrective measures and decision-making processes.